NAMPT anticorps (AA 1-280)

N° du produit ABIN7161574

Détail du produit anti-NAMPT anticorps

Antigène: NAMPT (Nicotinamide phosphoribosyltransferase (NAMPT))

Épitope: AA 1-280

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAMPT est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Nicotinamide phosphoribosyltransferase protein (1-280AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur NAMPT

Antigène: NAMPT (Nicotinamide phosphoribosyltransferase (NAMPT))

Autre désignation: NAMPT (NAMPT Produits)

Synonymes: anticorps 1110035O14Rik, anticorps PBEF, anticorps PBEF1, anticorps VF, anticorps VISFATIN, anticorps AI314458, anticorps AI480535, anticorps NAmPRTase, anticorps Pbef, anticorps Pbef1, anticorps Visfatin, anticorps visfatin, anticorps pbef, anticorps pbef1, anticorps nicotinamide phosphoribosyltransferase, anticorps Nicotinamide phosphoribosyltransferase, anticorps nicotinamide phosphoribosyltransferase S homeolog, anticorps NAMPT, anticorps Nampt, anticorps nampt, anticorps Smon_0680, anticorps Mrub_2845, anticorps Cseg_3704, anticorps BC1002_3997, anticorps Ftrac_2686, anticorps Varpa_5681, anticorps Celal_3900, anticorps Deima_0880, anticorps BC1001_3724, anticorps Celly_1696, anticorps Clole_1542, anticorps Tsp_05934, anticorps nampt.S

Sujet:

Background: Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation of clock target gene expression by releasing the core clock component: CLOCK-ARNTL/BMAL1 heterodimer from NAD-dependent SIRT1-mediated suppression (By similarity).

Aliases: 1110035O14Rik antibody, AI314458 antibody, AI480535 antibody, DKFZP666B131 antibody, EC 2.4.2.12 antibody, MGC117256 antibody, NAmPRTase antibody, Nampt antibody, NAMPT_HUMAN antibody, Nicotinamide phosphoribosyltransferase antibody, PBEF 1 antibody, PBEF antibody, PBEF1 antibody, Pre B cell colony enhancing factor 1 antibody, Pre B cell colony enhancing factor antibody, Pre B cell enhancing factor antibody, Pre-B cell-enhancing factor antibody, Pre-B-cell colony-enhancing factor 1 antibody, VF antibody, Visfatin antibody

UniProt: P43490